This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Palgrave Macmillan Announces Acquisition Of BioSocieties Journal From The London School Of Economics And Political Science

LONDON and NEW YORK, February 11, 2013 /PRNewswire/ --

Palgrave Macmillan is pleased to announce its acquisition of BioSocieties, an interdisciplinary journal for the social studies of life sciences, from the London School of Economics and Political Science.

The first journal of its kind, BioSocieties is committed to the scholarly exploration of the crucial social, ethical and policy implications of developments in the life sciences and biomedicine. BioSocieties is available via print or digital subscription, and also offers authors the option to publish their articles with immediate open access upon publication.

The quarterly journal, which has been published by Palgrave Macmillan for four years, will continue with the same editorial team led by Professor Nikolas Rose, Head of the Department of Social Science Health and Medicine at King's College London.

David Bull, Publishing Director of Journals and Reference at Palgrave Macmillan said: "We're delighted that we have added this young, exciting and international journal to the portfolio of journals we own.

"Life sciences and biomedicine is an exciting and vibrant area of research, and BioSocieties is at the cutting edge of its field, providing a crucial forum for leading scientists, social researchers, clinicians, regulators and other stakeholders."

Professor Paul Kelly, pro-director of teaching and learning at LSE, said: "Since its launch at LSE five years ago, BioSocieties has become the journal of choice not only for social scientists, but also for life scientists interested in the larger social, ethical and policy implications of their work. The School is delighted that the acquisition of BioSocieties by Palgrave Macmillan will ensure the journal continues to promote the findings of innovative research in this most exciting and challenging of fields of interdisciplinary endeavour."

Professor Nikolas Rose, Head of the Department of Social Science Health and Medicine at King's College London said: "I'm looking forward to continuing my working relationship with the team at Palgrave Macmillan. Together we will ensure BioSocieties carries on breaking out from the disciplinary boundaries within the social sciences and humanities, and develops new ways of thinking about the relations between biology and sociality and between the life sciences and society."

Notes to editors:

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,880.36 -31.75 -0.19%
S&P 500 1,970.07 +0.12 0.01%
NASDAQ 4,462.9020 +20.2040 0.45%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs